KR20030081906A - 아시클로버함유 외용필름형성 하이드로겔 제제 - Google Patents
아시클로버함유 외용필름형성 하이드로겔 제제 Download PDFInfo
- Publication number
- KR20030081906A KR20030081906A KR1020020020357A KR20020020357A KR20030081906A KR 20030081906 A KR20030081906 A KR 20030081906A KR 1020020020357 A KR1020020020357 A KR 1020020020357A KR 20020020357 A KR20020020357 A KR 20020020357A KR 20030081906 A KR20030081906 A KR 20030081906A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- acyclovir
- film
- forming
- sodium alginate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (2)
- 유효활성물질인 아시클로버 1∼10중량%, 유계형성제인 라우로마크로골-32-글리세라이드 20~30중량%, 계면활성제인 폴리글리세릴-6-디올레이트 0.5∼2중량%, 보조계면활성제인 프로필렌 글리콜 모노 라우레이트 1∼5중량%, 가소제인 글리세린 10∼30중량%, 필름형성제인 소디움 알기네이트 1-4중량% 및 정제수로 조성된 항 바이러스 작용을 갖는 아시클로버 함유 외용 필름형성 하이드로겔 조성물.
- 유계형성제인 라우로마크로골-32-글리세라이드 20∼30중량%, 계면활성제인 폴리글리세린-6-디올레이트 0.5∼2중량% 및 보조계면활성제인 프로필렌글리콜모노라우레이트 1∼5중량%을 60∼70℃로 가온, 용융시킨후, 여기에 유효활성물질인 아시클로버 1∼10중량%을 넣고 50∼60℃에서 교반하여 유상을 제조한후, 필름형성제인 소디움알기네이트 1-4중량%를 정제수에 균질하게 팽윤시킨후, 가소제인 글리세린 10-30중량%을 가하고 균질하게 혼합, 교반하고, 55∼60℃로 가온하여 수상을 제조하고, 얻어진 유상과 수상을 50∼60℃에서 교반 혼합, 유화시키고, 35∼40℃에서 일야 방치시켜 제조함을 특징으로 하는 항 바이러스 작용을 갖는 아시클로버 함유 외용필름형성 하이드로겔 조성물의 제조방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0020357A KR100433363B1 (ko) | 2002-04-15 | 2002-04-15 | 아시클로버함유 외용필름형성 하이드로겔 제제 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0020357A KR100433363B1 (ko) | 2002-04-15 | 2002-04-15 | 아시클로버함유 외용필름형성 하이드로겔 제제 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030081906A true KR20030081906A (ko) | 2003-10-22 |
KR100433363B1 KR100433363B1 (ko) | 2004-05-28 |
Family
ID=32378980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0020357A KR100433363B1 (ko) | 2002-04-15 | 2002-04-15 | 아시클로버함유 외용필름형성 하이드로겔 제제 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100433363B1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102564041B1 (ko) | 2021-04-30 | 2023-08-04 | 단국대학교 천안캠퍼스 산학협력단 | 피부투과도가 상승된 아시클로버를 함유한 외용 투명필름형성겔 제제의 개발 및 제조방법 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA853488B (en) * | 1984-05-10 | 1986-12-30 | American Home Prod | Transdermal dosage form |
US4725439A (en) * | 1984-06-29 | 1988-02-16 | Alza Corporation | Transdermal drug delivery device |
IT1248666B (it) * | 1990-05-30 | 1995-01-26 | Fidia Spa | Gel in forma di film autosupportanti altamente idrati, processo per laloro preparazione e impiego nella terapia di lesioni e/o patologie cutanee |
JPH061718A (ja) * | 1992-06-17 | 1994-01-11 | Sumitomo Pharmaceut Co Ltd | フィルム状皮膚適用製剤組成物 |
CA2103846A1 (en) * | 1992-08-13 | 1994-02-14 | Patricia-Ann Truter | Hydrogel composition and methods of making it |
US6348212B2 (en) * | 1999-05-18 | 2002-02-19 | Lectec Corporation | Treating traumatic burns or blisters of the skin |
KR100337161B1 (ko) * | 2000-04-10 | 2002-05-18 | 서경배 | 폴리우레탄 및 폴리에테르를 함유하는 약물 전달용 필름형성제 및 이를 함유하는 경피 투여형 제제 |
KR100452972B1 (ko) * | 2000-05-16 | 2004-10-14 | 주식회사 삼양사 | 경피투여용 하이드로젤 조성물 |
-
2002
- 2002-04-15 KR KR10-2002-0020357A patent/KR100433363B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR100433363B1 (ko) | 2004-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6495160B2 (en) | Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs | |
EP0295411B1 (en) | Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or a salt thereof | |
EP0083108B1 (en) | Aqueous solution containing ubidecarenone | |
MXPA02004930A (es) | Composiciones estroprogestativos topicos con efecto sistemico. | |
FI92149C (fi) | Menetelmä ihon kautta annettavan bunatsosiinia sisältävän farmaseuttisen valmisteen valmistamiseksi | |
CZ284097A3 (en) | Topic applicable pharmaceutical composition, process of its preparation and use | |
JPH057371B2 (ko) | ||
JPS6135166B2 (ko) | ||
HU228863B1 (en) | Topical hormonal composition containing synthetic progestogen with systemic effect | |
JPH0131485B2 (ko) | ||
TWI401078B (zh) | 化學上安定的4-羥基泰莫西芬(Tamoxifen)組成物 | |
JPH0250882B2 (ko) | ||
AU690112B2 (en) | Topically administrable zinc phthalocyanine compositions | |
WO1995004551A1 (fr) | Preparation absorbable par voie percutanee | |
KR100433363B1 (ko) | 아시클로버함유 외용필름형성 하이드로겔 제제 | |
EP0634170B1 (en) | Compositions containing 8-hydroxy-quinoline for use in the treatment of hyperproliferative skin diseases | |
JPS6218526B2 (ko) | ||
JPH0676327B2 (ja) | ステロイド軟膏製剤 | |
CN106560175A (zh) | 一种薄荷脑-樟脑低共熔物纳米乳原位凝胶制剂 | |
EP0322197B1 (en) | New dithranol compositions | |
EP2255790B1 (en) | Liposome composition comprising naproxen, and a method of obtaining same | |
JPH10316555A (ja) | 高分子化合物を含有するリポソーム外用剤 | |
FI96742B (fi) | Minoksidiilia sisältävä 1-faasigeelikoostumus ja menetelmä sen valmistamiseksi | |
JPH1121229A (ja) | 抗真菌性外用製剤およびその製造方法 | |
JPS63270614A (ja) | 透明ゲル基剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130313 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20140319 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20150311 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20160322 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20170512 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20180510 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20190510 Year of fee payment: 16 |